Calgary-based Fluid Biomed Company has raised USD 27 million in a Series A round to further the opportunities for the field-changing flow-diverting brain stent. The stent for the treatment of brain aneurysms is viewed as one of the major innovations in the industry of medical devices. Fluid Biomed’s stent is designed and made from a
read more..